[Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
Cybulska
Barbara
B
Instytut Zywności i Zywienia, Warszawa.
D016632:Apolipoprotein A-I / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000097:blood* / Q000503:physiopathology*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D018570:Risk Assessment; D012307:Risk Factors
D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D008074:Lipoproteins